{ "company_number": "06709883", "name": "Instil Bio (UK) Limited", "url": "/company/06709883", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2008-09-29", "dissolved_on": null, "sic_codes": [ { "code": "72110", "description": "Research and experimental development on biotechnology", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/72110" }, { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 1380673, "url": "/address/1380673", "line1": "ALDERLEY PARK BLOCK 19", "line2": "CONGLETON ROAD", "post_town": "MACCLESFIELD", "county": "", "country": "ENGLAND", "postcode": "SK10 4TF" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06709883", "previous_names": [ { "name": "Cellular Therapeutics Ltd", "ceased_on": "2018-03-29" }, { "name": "Immetacyte Limited", "ceased_on": "2020-07-02" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-09-30", "last_made_up": "2024-12-31", "category": "SMALL", "filings": [ { "url": "/company/06709883/accounts/2024-12-31", "pdf_url": "/company/06709883/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-01-01", "period_end": "2024-12-31", "entity_name": "Instil Bio (UK) Limited", "dormant": false, "average_employees": "68.00", "tangible_fixed_assets": "0.00", "debtors": "1861724.00", "cash_bank_in_hand": "38067.00", "current_assets": "1899791.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-5095919.00", "total_assets_less_current_liabilities": "-5095919.00", "net_assets_liabilities": "-5155919.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31652.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-5533563.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/06709883/accounts/2023-12-31", "pdf_url": "/company/06709883/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-01-01", "period_end": "2023-12-31", "entity_name": "Instil Bio (UK) Limited", "dormant": false, "average_employees": "108.00", "tangible_fixed_assets": "926987.00", "debtors": "2300109.00", "cash_bank_in_hand": "431150.00", "current_assets": "2731259.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-8516648.00", "total_assets_less_current_liabilities": "-7589661.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31652.00", "turnover": null, "other_operating_income": null, "cost_sales": "5126544.00", "gross_profit_loss": null, "administrative_expenses": "18031181.00", "raw_materials_consumables": null, "staff_costs": "7923039.00", "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": "-14906839.00", "tax_on_profit": "0.00", "profit_loss_for_period": "-14906839.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/06709883/accounts/2020-02-29", "pdf_url": "/company/06709883/accounts/2020-02-29.pdf", "made_up_date": "2020-02-29", "period_start": "2019-10-01", "period_end": "2020-02-29", "entity_name": "Instil Bio (UK) Limited (Formerly Immetacyte Limited)", "dormant": false, "average_employees": "23.00", "tangible_fixed_assets": "540751.00", "debtors": "1282714.00", "cash_bank_in_hand": "370586.00", "current_assets": "1653300.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "710960.00", "total_assets_less_current_liabilities": "1251711.00", "net_assets_liabilities": "1251711.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31652.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "364883.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2021.zip" }, { "url": "/company/06709883/accounts/2019-09-30", "pdf_url": "/company/06709883/accounts/2019-09-30.pdf", "made_up_date": "2019-09-30", "period_start": "2019-09-30", "period_end": "2019-09-30", "entity_name": "Immetacyte Limited", "dormant": false, "average_employees": "14.00", "tangible_fixed_assets": "426349.00", "debtors": "1008933.00", "cash_bank_in_hand": "967719.00", "current_assets": "1976652.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "470202.00", "total_assets_less_current_liabilities": "896551.00", "net_assets_liabilities": "886828.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31652.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/06709883/accounts/2018-09-30", "pdf_url": "/company/06709883/accounts/2018-09-30.pdf", "made_up_date": "2018-09-30", "period_start": "2018-09-30", "period_end": "2018-09-30", "entity_name": "Immetacyte Limited", "dormant": false, "average_employees": "11.00", "tangible_fixed_assets": "117029.00", "debtors": "387137.00", "cash_bank_in_hand": "111401.00", "current_assets": "498538.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "147033.00", "total_assets_less_current_liabilities": "264062.00", "net_assets_liabilities": "238810.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31652.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2019.zip" }, { "url": "/company/06709883/accounts/2017-09-30", "pdf_url": "/company/06709883/accounts/2017-09-30.pdf", "made_up_date": "2017-09-30", "period_start": "2017-09-30", "period_end": "2017-09-30", "entity_name": "Immetacyte Limited", "dormant": false, "average_employees": "11.00", "tangible_fixed_assets": "53983.00", "debtors": "336199.00", "cash_bank_in_hand": "3696.00", "current_assets": "339895.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "99292.00", "total_assets_less_current_liabilities": "153275.00", "net_assets_liabilities": "111655.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "29902.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2018.zip" }, { "url": "/company/06709883/accounts/2016-09-30", "pdf_url": "/company/06709883/accounts/2016-09-30.pdf", "made_up_date": "2016-09-30", "period_start": "2016-09-30", "period_end": "2016-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "92801.00", "debtors": "118728.00", "cash_bank_in_hand": "86928.00", "current_assets": "205656.00", "creditors_due_within_one_year": "113880.00", "creditors_due_after_one_year": "50874.00", "net_current_assets_liabilities": "91776.00", "total_assets_less_current_liabilities": "184577.00", "net_assets_liabilities": "133703.00", "called_up_share_capital": "25902.00", "profit_loss_account_reserve": "4201.00", "shareholder_funds": "133703.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2017.zip" }, { "url": "/company/06709883/accounts/2015-09-30", "pdf_url": "/company/06709883/accounts/2015-09-30.pdf", "made_up_date": "2015-09-30", "period_start": "2015-09-30", "period_end": "2015-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "110258.00", "debtors": "205374.00", "cash_bank_in_hand": "14387.00", "current_assets": "219761.00", "creditors_due_within_one_year": "190161.00", "creditors_due_after_one_year": "60933.00", "net_current_assets_liabilities": "29600.00", "total_assets_less_current_liabilities": "139858.00", "net_assets_liabilities": "78925.00", "called_up_share_capital": "9502.00", "profit_loss_account_reserve": "31423.00", "shareholder_funds": "78925.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2016.zip" }, { "url": "/company/06709883/accounts/2014-09-30", "pdf_url": "/company/06709883/accounts/2014-09-30.pdf", "made_up_date": "2014-09-30", "period_start": "2014-09-30", "period_end": "2014-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "5894.00", "debtors": "2.00", "cash_bank_in_hand": "237103.00", "current_assets": "237105.00", "creditors_due_within_one_year": "167208.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "69897.00", "total_assets_less_current_liabilities": "75791.00", "net_assets_liabilities": "75791.00", "called_up_share_capital": "47502.00", "profit_loss_account_reserve": "28289.00", "shareholder_funds": "75791.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2015.zip" }, { "url": "/company/06709883/accounts/2013-09-30", "pdf_url": "/company/06709883/accounts/2013-09-30.pdf", "made_up_date": "2013-09-30", "period_start": "2013-09-30", "period_end": "2013-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "532.00", "debtors": "2.00", "cash_bank_in_hand": "341899.00", "current_assets": "341901.00", "creditors_due_within_one_year": "272561.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "69340.00", "total_assets_less_current_liabilities": "69872.00", "net_assets_liabilities": "69872.00", "called_up_share_capital": "47502.00", "profit_loss_account_reserve": "22370.00", "shareholder_funds": "69872.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" }, { "url": "/company/06709883/accounts/2012-09-30", "pdf_url": "/company/06709883/accounts/2012-09-30.pdf", "made_up_date": "2012-09-30", "period_start": "2012-09-30", "period_end": "2012-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "2.00", "cash_bank_in_hand": "66770.00", "current_assets": "66772.00", "creditors_due_within_one_year": "4418.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "62354.00", "total_assets_less_current_liabilities": "62354.00", "net_assets_liabilities": "62354.00", "called_up_share_capital": "47502.00", "profit_loss_account_reserve": "14852.00", "shareholder_funds": "62354.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2013.zip" }, { "url": "/company/06709883/accounts/2011-09-30", "pdf_url": "/company/06709883/accounts/2011-09-30.pdf", "made_up_date": "2011-09-30", "period_start": "2011-09-30", "period_end": "2011-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "47617.00", "current_assets": "47617.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "47617.00", "total_assets_less_current_liabilities": "47617.00", "net_assets_liabilities": "47617.00", "called_up_share_capital": "47700.00", "profit_loss_account_reserve": "-83.00", "shareholder_funds": "47617.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2012.zip" }, { "url": "/company/06709883/accounts/2010-09-30", "pdf_url": "/company/06709883/accounts/2010-09-30.pdf", "made_up_date": "2010-09-30", "period_start": "2010-09-30", "period_end": "2010-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "2.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "2.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": null, "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2011.zip" }, { "url": "/company/06709883/accounts/2009-09-30", "pdf_url": "/company/06709883/accounts/2009-09-30.pdf", "made_up_date": "2009-09-30", "period_start": "2009-09-30", "period_end": "2009-09-30", "entity_name": "Cellular Therapeutics Ltd", "dormant": true, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "0.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "2.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2010.zip" } ], "pdf_only_filings": [ { "made_up_date": "2022-12-31", "filing_date": "2023-12-21", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06709883/accounts/2022-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06709883/filing-history/MzQwMzc4NzAyNGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2021-12-31", "filing_date": "2022-12-14", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/06709883/accounts/2021-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06709883/filing-history/MzM2MTc5OTg3OWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2020-12-31", "filing_date": "2021-10-26", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/06709883/accounts/2020-12-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06709883/filing-history/MzMxNzU2Nzk3M2FkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06709883/filing-history" }, "confirmation_statement": { "next_due": "2026-10-12", "last_made_up": "2025-09-28" }, "officers": [], "psc": [ { "name": "Mr Ryan Guest", "kind": "individual-person-with-significant-control", "person_url": "/person/4367233", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2020-03-02", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Robert Hawkins", "kind": "individual-person-with-significant-control", "person_url": "/person/4248634", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2020-03-02", "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T20:59:03.591456+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }